CAS: 2305154-31-6
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
N-(3-Bromo-2-fluorophenyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine REF: AN-AG01KK6JCAS: 2305154-31-6 | 97% | 164,00 €~333,00 € | Jue 09 May 24 | |
JCN037 REF: TM-T8431CAS: 2305154-31-6 | 100% | 52,00 €~762,00 € | Jue 16 May 24 | |
JCN037 REF: 3D-FSD15431CAS: 2305154-31-6 | Min. 95% | A consultar | Jue 20 Jun 24 |
N-(3-Bromo-2-fluorophenyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine
CAS:2305154-31-6
Fórmula:
C16H11BrFN3O2
Pureza:
97%
Peso molecular:
376.1798
Ref: AN-AG01KK6J
25mg | 164,00 € | |
50mg | 197,00 € | |
100mg | 333,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
JCN037
CAS:2305154-31-6
JCN037 is potent, non-covalent and brain-penetrant inhibitor of EGFR(EGFR, p-wtEGFR and pEGFRvⅢ with IC50 of …
Fórmula:
C16H11BrFN3O2
Pureza:
100%
Forma y color:
Solid
Peso molecular:
376.18
Ref: TM-T8431
1mg | 52,00 € | |
5mg | 142,00 € | |
10mg | 212,00 € | |
25mg | 355,00 € | |
50mg | 527,00 € | |
100mg | 762,00 € | |
1ml*10 (DMSO) | 157,00 € |
Entrega estimada en Estados Unidos, el Jueves 16 de Mayo de 2024
JCN037
CAS:2305154-31-6
JCN037 is a potent, selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor in clinical …
Fórmula:
C16H11BrFN3O2
Pureza:
Min. 95%
Peso molecular:
376.18 g/mol
Ref: 3D-FSD15431
1mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 20 de Junio de 2024